Safety and Efficacy of 4-weeks Treatment of BIBW 2948 BS in Patients With Chronic Obstructive Bronchitis

NCT00726479 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive
Bronchitis, Chronic

Interventions

DRUG: BIBW 2948 BS

Sponsor

Boehringer Ingelheim